Hutchinson-Gilford progeria syndrome, cardiovascular disease and oxidative stress

作者: Laia Trigueros-Motos

DOI: 10.2741/226

关键词: Myocardial infarctionPathologicalProgerinPremature agingDiseaseBioinformaticsMedicineLaminOxidative stressProgeriaGeneral Biochemistry, Genetics and Molecular BiologyGeneral Immunology and MicrobiologyGeneral Medicine

摘要: Hutchinson-Gilford Progeria Syndrome (HGPS), a rare human disease characterized by premature aging, is mainly caused the abnormal accumulation of progerin, mutant form mammalian nuclear envelope component lamin A. HGPS patients exhibit vascular alterations and die at an average age 13 years, predominantly from myocardial infarction or stroke. Animal models have been valuable tool in study pathological processes implicated origin this its associated cardiovascular alterations. Some molecular mechanisms might be relevant to process normal since progerin detected cells elderly humans. Conversely, linked such as increase oxidative stress, pathogenic HGPS. In review, we discuss recent advances understanding underlying with HGPS, potential role therapeutic approaches for treatment devastating disease.

参考文章(117)
William Reichel, Rafael Garcia-Bunuel, Pathologic findings in progeria: myocardial fibrosis and lipofuscin pigment. American Journal of Clinical Pathology. ,vol. 53, pp. 243- 253 ,(1970) , 10.1093/AJCP/53.2.243
Joanna M. Bridger, Nicole Foeger, Ian R. Kill, Harald Herrmann, The nuclear lamina. Both a structural framework and a platform for genome organization. FEBS Journal. ,vol. 274, pp. 1354- 1361 ,(2007) , 10.1111/J.1742-4658.2007.05694.X
C.N. Oliver, B.W. Ahn, E.J. Moerman, S. Goldstein, E.R. Stadtman, Age-related changes in oxidized proteins. Journal of Biological Chemistry. ,vol. 262, pp. 5488- 5491 ,(1987) , 10.1016/S0021-9258(18)45598-6
Reed E. Pyeritz, Malcolm K. Brenner, Edwin M. Horwitz, Darwin J. Prockop, Lorraine A. Fitzpatrick, Winston W. K. Koo, Patricia L. Gordon, Michael Neel, Michael Sussman, Paul Orchard, Jeffrey C. Marx, Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta Nature Medicine. ,vol. 5, pp. 309- 313 ,(1999) , 10.1038/6529
C F Lehner, V Kurer, H M Eppenberger, E A Nigg, The nuclear lamin protein family in higher vertebrates. Identification of quantitatively minor lamin proteins by monoclonal antibodies. Journal of Biological Chemistry. ,vol. 261, pp. 13293- 13301 ,(1986) , 10.1016/S0021-9258(18)69303-2
F. Lin, H.J. Worman, Structural organization of the human gene encoding nuclear lamin A and nuclear lamin C. Journal of Biological Chemistry. ,vol. 268, pp. 16321- 16326 ,(1993) , 10.1016/S0021-9258(19)85424-8
M Sinensky, L A Beck, S Leonard, R Evans, Differential inhibitory effects of lovastatin on protein isoprenylation and sterol synthesis. Journal of Biological Chemistry. ,vol. 265, pp. 19937- 19941 ,(1990) , 10.1016/S0021-9258(17)45464-0
Franklin H. Epstein, Daniel Steinberg, Sampath Parthasarathy, Thomas E. Carew, John C. Khoo, Joseph L. Witztum, Beyond Cholesterol New England Journal of Medicine. ,vol. 320, pp. 915- 924 ,(1989) , 10.1056/NEJM198904063201407
D Amin, SA Cornell, SK Gustafson, SJ Needle, JW Ullrich, GE Bilder, MH Perrone, Bisphosphonates used for the treatment of bone disorders inhibit squalene synthase and cholesterol biosynthesis. Journal of Lipid Research. ,vol. 33, pp. 1657- 1663 ,(1992) , 10.1016/S0022-2275(20)41388-4
Maria Eriksson, W. Ted Brown, Leslie B. Gordon, Michael W. Glynn, Joel Singer, Laura Scott, Michael R. Erdos, Christiane M. Robbins, Tracy Y. Moses, Peter Berglund, Amalia Dutra, Evgenia Pak, Sandra Durkin, Antonei B. Csoka, Michael Boehnke, Thomas W. Glover, Francis S. Collins, Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome Nature. ,vol. 423, pp. 293- 298 ,(2003) , 10.1038/NATURE01629